XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation has been recognized in operating results as follows:

 

(in thousands)

 

Years ended December 31,

 

 

2024

 

 

2023

 

Research and development expenses

 

$

1,660

 

 

$

1,279

 

Selling, general and administrative expenses

 

 

3,100

 

 

 

3,230

 

Total stock-based compensation

 

$

4,760

 

 

$

4,509

 

Schedule of Assumptions to Estimate Fair Value of Stock Option Awards

The estimated fair value of stock option awards was determined on the date of grant using the Black-Scholes option valuation model with the following assumptions during the years indicated below:

 

 

Years ended December 31,

 

2024

 

2023

Risk-free interest rate (range)

 

4.04% - 4.27%

 

3.56% - 4.06%

Dividend yield

 

0%

 

0%

Expected volatility (range)

 

103% - 107%

 

105% - 110%

Expected term (in years)

 

5.8 years

 

5.2 years

Summary of Stock Option Activity

A summary of stock option activity and of changes in stock options outstanding is presented below:

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price
Per Share

 

 

Intrinsic
Value

 

 

Weighted-
Average
Remaining
Contractual
Life

Balance outstanding, December 31, 2023

 

 

6,650,954

 

 

$

4.27

 

 

$

23,926

 

 

7.9 years

Granted

 

 

1,905,096

 

 

$

3.40

 

 

 

 

 

 

Exercised

 

 

(139,430

)

 

$

2.67

 

 

$

139,371

 

 

 

Forfeited and expired

 

 

(81,855

)

 

$

26.39

 

 

 

 

 

 

Balance Outstanding, December 31, 2024

 

 

8,334,765

 

 

$

3.88

 

 

$

11,668,989

 

 

7.5 years

Vested and exercisable, December 31, 2024

 

 

4,723,009

 

 

$

4.48

 

 

$

6,404,133

 

 

6.7 years

Vested and expected to vest, December 31, 2024

 

 

8,132,737

 

 

$

3.91

 

 

$

11,344,268

 

 

7.4 years